RFC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.307000E-01
Normal-vs-Stage2
5.581600E-01
Normal-vs-Stage3
2.185200E-01
Normal-vs-Stage4
8.930600E-01
Stage1-vs-Stage2
5.219800E-01
Stage1-vs-Stage3
1.995010E-01
Stage1-vs-Stage4
7.986400E-01
Stage2-vs-Stage3
1.969430E-01
Stage2-vs-Stage4
6.127600E-01
Stage3-vs-Stage4
2.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.069400E-01
Normal-vs-AfricanAmerican
3.404200E-01
Normal-vs-Asian
4.193200E-01
Caucasian-vs-AfricanAmerican
4.531200E-01
Caucasian-vs-Asian
6.062800E-01
AfricanAmerican-vs-Asian
6.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.706200E-01
Normal-vs-Female
7.170800E-01
Male-vs-Female
2.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.949800E-01
Normal-vs-Age(41-60Yrs)
6.705600E-01
Normal-vs-Age(61-80Yrs)
5.459200E-01
Normal-vs-Age(81-100Yrs)
7.290800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.493600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.152400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.367800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.778800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.290000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.885800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.612800E-01
Normal-vs-Daily Drinker
2.479800E-01
Normal-vs-Weekly Drinker
7.137800E-01
Normal-vs-Occasional Drinker
6.994400E-01
Normal-vs-Social Drinker
8.114800E-01
Non Drinker-vs-Daily Drinker
8.776200E-01
Non Drinker-vs-Weekly Drinker
4.864400E-01
Non Drinker-vs-Occasional Drinker
3.463400E-01
Non Drinker-vs-Social Drinker
2.655600E-01
Daily Drinker-vs-Weekly Drinker
4.647800E-01
Daily Drinker-vs-Occasional Drinker
2.688000E-01
Daily Drinker-vs-Social Drinker
2.034600E-01
Weekly Drinker-vs-Occasional Drinker
9.240200E-01
Weekly Drinker-vs-Social Drinker
7.864400E-01
Occasional Drinker-vs-Social Drinker
8.288400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.843600E-01
Normal-vs-Grade 2
9.478600E-01
Normal-vs-Grade 3
8.719400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.936800E-01
Grade 1-vs-Grade 3
1.810000E-01
Grade 1-vs-Grade 4
9.843600E-01
Grade 2-vs-Grade 3
1.876370E-01
Grade 2-vs-Grade 4
9.478600E-01
Grade 3-vs-Grade 4
8.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.947400E-01
Normal-vs-NonDiabetic
5.169200E-01
Diabetic-vs-NonDiabetic
2.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.091600E-01
Normal-vs-NoPancreatitis
4.980800E-01
Pancreatitis-vs-NoPancreatitis
6.091700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.807200E-01
Normal-vs-N1
5.190200E-01
N0-vs-N1
2.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.500400E-01
Normal-vs-TP53-NonMutant
8.706200E-01
TP53-Mutant-vs-TP53-NonMutant
2.916500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
